Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

JS006

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-1766 Copy Product Info
🥰Excellent
JS006 is a humanized IgG4κ monoclonal antibody inhibitor targeting TIGIT/CD155. It is applicable in the study of advanced and/or metastatic cancers, such as non-small cell lung cancer (NSCLC), advanced lymphoma, and advanced/metastatic triple-negative breast cancer (TNBC), particularly when resistance to PD-1/PD-L1 inhibitors has developed.

JS006

Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
JS006 is a humanized IgG4κ monoclonal antibody inhibitor targeting TIGIT/CD155. It is applicable in the study of advanced and/or metastatic cancers, such as non-small cell lung cancer (NSCLC), advanced lymphoma, and advanced/metastatic triple-negative breast cancer (TNBC), particularly when resistance to PD-1/PD-L1 inhibitors has developed.
Storage & Solubility Information
StorageStore at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: